Inactive Instrument

XPED Stock Australian S.E.

Advanced Medical Equipment & Technology

End-of-day quote Australian S.E.
- ^AUD	-

24/08	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
12/02	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI

Oakridge International Limited is an Australia-based Internet of things (IoT) and healthcare technology company. The Company is primarily engaged in the business of selling professional healthcare technology equipment and solutions to healthcare facilities. The Companyâ€™s segments include Healthcare technology, Technology development and Geothermal projects. The Technology development segment is focused on the IoT technology. The Healthcare technology segment operates through its wholly owned subsidiary, JCT Healthcare Pty Ltd (JCT), which is a provider of technology solutions for the healthcare sector. JCT develops and distributes its own range of nurse call hardware and software solutions for use across multiple healthcare sectors including hospitals, aged care, disability care and supported independent living. The Geothermal projects segment includes Sokoria Geothermal Project, Ngebel Geothermal Project, Dairi Prima Geothermal Project and Puga Geothermal Project.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	2.56M 1.78M 1.58M 1.48M 1.34M 2.54M 171M 17.85M 6.92M 87.43M 6.68M 6.53M 281M	P/E 2025	-13.4x	P/E 2026	21.1x
Enterprise Value	2.02M 1.4M 1.25M 1.16M 1.06M 2M 135M 14.07M 5.45M 68.92M 5.26M 5.15M 221M	EV / Sales 2025	0.6x	EV / Sales 2026	0.41x
Free-Float	18.74%	Yield 2025 *	-	Yield 2026	-

24/08	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
12/02	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
22/08/25	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
03/03/25	Oakridge International Limited Announces Board Changes	CI
19/02/25	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI
29/08/24	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI
16/04/24	Oakridge International Enters AU$500,000 Shares and Option Subscription Agreement	MT
06/03/24	Oakridge International Gets Nearly AU$180,000 R&D Tax Rebate	MT
28/02/24	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
21/08/23	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI
29/03/23	Oakridge International Limited Announces Change of Principal Place of Business	CI
18/02/23	Oakridge International Shrinks Fiscal H1 Loss by 61%	MT
17/02/23	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	CI

21/12/21	Oakridge International : Unmarketable Parcel Sale Facility	PU
02/06/17	XPED Ltd Company Update	AW
02/06/17	XPED Ltd Receives 20 Million Unit Order for iPark	AW
22/05/17	XPED Ltd Complete Jemsoft Acquisition	AW
19/05/17	XPED Ltd Lenze App Delivered	AW

Manager	Title	Age	Since
Con Unerkov CEO	Chief Executive Officer	57	03/02/2021
Julie Edwards SEC	Corporate Secretary	-	-

Director	Title	Age	Since
Con Unerkov CHM	Chairman	57	31/12/2019
Peter Whelan BRD	Director/Board Member	-	29/01/2021
Wally Pastuch BRD	Director/Board Member	-	03/03/2025

XPED Stock Australian S.E.

Stocks

Advanced Medical Equipment & Technology

Valuation: XPED

Latest news: XPED

Press Releases: XPED

Managers and Directors: XPED

Medical Software & Technology Services

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	+0.35%	-2.99%	+20.52%	+30.32%	242B
DANAHER CORPORATION	+1.09%	-4.65%	-0.43%	-0.93%	150B
INTUITIVE SURGICAL, INC.	-2.32%	-3.27%	-13.35%	+35.02%	138B
BOSTON SCIENTIFIC CORPORATION	-1.46%	-3.01%	-56.23%	-17.36%	61.74B
EDWARDS LIFESCIENCES CORPORATION	-0.05%	-1.32%	+10.48%	+19.48%	49.08B
SIEMENS HEALTHINEERS AG	-1.47%	-2.74%	-22.16%	-21.22%	47.43B
AGILENT TECHNOLOGIES, INC.	+0.66%	-2.90%	+18.46%	+50.25%	47.3B
VEEVA SYSTEMS INC.	-3.05%	-2.62%	-7.75%	+36.34%	44.25B
WATERS CORPORATION	-0.08%	-1.92%	+29.48%	+58.80%	41.78B
Average	-0.70%	-2.50%	-2.33%	+21.19%	91.4B
Weighted average by Cap.	-0.42%	-2.98%	+0.98%	+21.11%

	2025	2026
Net sales	2.43M 1.69M 1.5M 1.4M 1.28M 2.41M 163M 16.97M 6.58M 83.11M 6.35M 6.21M 267M	3.45M 2.4M 2.13M 1.99M 1.81M 3.41M 230M 24.04M 9.31M 118M 8.99M 8.8M 378M
Net income	-129K -89.52K -79.53K -74.23K -67.66K -128K -8.61M -898K -348K -4.4M -336K -329K -14.12M	109K 75.88K 67.42K 62.92K 57.35K 108K 7.29M 761K 295K 3.73M 285K 279K 11.97M
Net Debt	-267K -186K -165K -154K -140K -265K -17.84M -1.86M -722K -9.12M -697K -682K -29.27M	-542K -377K -335K -312K -285K -537K -36.23M -3.78M -1.47M -18.52M -1.41M -1.38M -59.43M